Les avocats de Foley évaluent les considérations critiques en matière de PI pour les entreprises émergentes du secteur des dispositifs médicaux

Foley & Lardner LLP attorneys Shabbi Khan, Nate Beaver, Austin Kim, and Jeff Simon authored the Med Device Online article, “Critical Considerations For IP & Patents For Emerging Medical Device Companies.”

The authors explore the critical role of intellectual property in the growing global medical device market, outlining strategic considerations innovators need to weigh when selecting the right type of patent filing and highlighting the importance of filing at the right time, factors involved in conducting a Freedom to Operate (FTO) analysis, and considerations for submissions to the U.S. Food and Drug Administration.

“A well-executed IP strategy is vital for medical device companies,” the authors conclude. “Understanding the different types of IP filings and strategically timing them, together with conducting FTO analyses, are critical steps in a successful IP plan. Strategic IP management not only secures competitive advantages but also enhances investment appeal, ultimately driving business success.”